Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mirsada Durmisi"'
Autor:
Mirsada Durmisi, Nina Kaegi-Braun, Natasha A. Müller, Carla Wunderle, Pascal Tribolet, Zeno Stanga, Beat Mueller, Philipp Schuetz
Publikováno v:
Nutrition Journal, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Introduction Cortisol is a metabolically active stress hormone that may play a role in the pathogenesis of malnutrition. We studied the association between admission cortisol levels and nutritional parameters, disease severity, and response
Externí odkaz:
https://doaj.org/article/bd51ecc89bc54a69ab5b5fe55ca716ea
Autor:
Andrea Haubitz-Eschelbach, Mirsada Durmisi, Sebastian Haubitz, Alexander Kutz, Beat Mueller, Jeffrey L. Greenwald, Philipp Schuetz
Publikováno v:
Swiss Medical Weekly, Vol 149, Iss 5152 (2019)
INTRODUCTION The physical appearance of a physician may influence patients’ perceptions of that physician’s quality of care. There is a lack of studies investigating whether physician appearance is indeed associated with patient satisfaction and
Externí odkaz:
https://doaj.org/article/8f3894e45ed6477b8bd5641e3d3db542
Autor:
Natasha Anouschka Müller, Nina Kaegi-Braun, Mirsada Durmisi, Carla Gressies, Pascal Tribolet, Zeno Stanga, Beat Mueller, Philipp Schuetz
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 108:e240-e248
Context During illness, deiodination of thyroxine (T4) to triiodothyronine (T3) is downregulated. This is called “low T3 syndrome”, an adaptive metabolic mechanism to reduce energy expenditure and prevent catabolism. Objective We aimed to investi
Autor:
Philipp Schuetz, Sebastian Haubitz, Alexander Kutz, Beat Mueller, Andrea Haubitz-Eschelbach, Mirsada Durmisi, Jeffrey L. Greenwald
Publikováno v:
Swiss Medical Weekly.
Introduction The physical appearance of a physician may influence patientsr perceptions of that physicianrs quality of care. There is a lack of studies investigating whether physician appearance is indeed associated with patient satisfaction and mort
Autor:
Johannes von Kempis, Mirsada Durmisi, Hendrik Schulze-Koops, Caroline Hasler, Ruediger B Mueller, Paul Hasler, Alexander Souza, Frederik Mattow, Florian Popp, Andrea Rubbert-Roth
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 8, Iss 10, p 1548 (2019)
Volume 8
Issue 10
Journal of Clinical Medicine, Vol 8, Iss 10, p 1548 (2019)
Volume 8
Issue 10
Introduction: Tofacitinib is an oral JAK inhibitor indicated for the treatment of rheumatoid arthritis (RA). The efficacy and safety of tofacitinib have been shown in several randomized clinical trials. The study presented here aimed to assess the cl